Immunomedics (IMMU) Misses Q1 EPS by 86c
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Price: $87.86 --0%
Financial Fact:
Research and development: 129.19K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 129.19K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Immunomedics (NASDAQ: IMMU) reported Q1 EPS of ($0.97), $0.86 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $690.49 million, versus $741.81 million reported last year.
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- SanDisk upgraded at JPMorgan after investor day; shares climb
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
